Información de la revista
Vol. 44. Núm. 6.
Páginas 267-271 (enero 2001)
Vol. 44. Núm. 6.
Páginas 267-271 (enero 2001)
Acceso a texto completo
Metástasis inguinal como primera manifestación de carcinoma de ovario con carcinoma concomitante de mama
Inguinal metastasis as the first manifestation of ovarian carcinoma with concomitant breast carcinoma
Visitas
8742
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
R. Musumeci, A. Banfi, G. Blois, G. Candiani, G. DePalo, F. DiRe, et al.
Lymphangiography in patients with ovarian epithelial cancer: an evaluation of 289 cases.
Cancer, 40 (1977), pp. 1444-1449
[2.]
P. Dvorestsky, K. Richards, C. Angel, L. Rabinowitz, M. Stoler, J. Beecham, et al.
Distribution of desease at autopsy in 100 women with ovarian cancer.
Hum Pathol, 19 (1988), pp. 57-63
[3.]
H. Abrams, R. Spiro, N. Goldstein.
Metastases in carcinoma: analysis of 1000 autopsied cases.
Cancer, 3 (1950), pp. 74-85
[4.]
E. Burghardt, F. Girardi, M. Lahousen, K. Tamussino, H. Stettner.
Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer.
Gynecol Oncol, 40 (1991), pp. 103-106
[5.]
S. Kehoe, D. Luesley, T. Rollason.
Ovarian carcinoma presenting with inguinal metastatic lymphadenopathy 33 months prior to intrabdominal disease.
Gynecol Oncol, 50 (1993), pp. 128-130
[6.]
K. McGonigle, M. Dudzinski.
Endometrioid carcinoma of the ovary presenting with an enlarged inguinal lymph node without evidence of abdominal carcinomatosis.
Gynecol Oncol, 45 (1992), pp. 225-228
[8.]
R. Yancik, L. Ries, J. Yates.
Ovarian cancer in the elderly: an analysis of surveillance, epidemiology and end results program data.
Am J Obstet Gynecol, 154 (1986), pp. 639-647
[9.]
R. Hightower, H. Nguyen, H. Averette, W. Hoskins, T. Harrison, A. Steren.
National survey of ovarian carcinoma IV: patterns of care and related survival for older patients.
Cancer, 73 (1994), pp. 377-383
[10.]
A. Bicher, G. Sarosy, E. Kohn, D. Adamo, P. Davis, J. Jacob, et al.
Age does not influence taxol dose intensity in recurrent carcinoma of the ovary.
Cancer, 71 (1993), pp. 594-600
[11.]
T. Cornelison, E. Reed.
Dose intensity analysis of high-dose carboplatin in refractory ovarian carcinoma relative to age.
Cancer, 71 (1993), pp. 650-655
[12.]
NIH Consensus conference ovarian Cancer.
Screening, treatment and follow-up.
Jama, 273 (1995), pp. 491-497
[13.]
The early breast cancer trialists' collaborative group.
Lancet, 351 (1998), pp. 1451-1467
[14.]
F. Bonilla, F. Pérez-López.
Cáncer de mama, 1.a ed, pp. 17-32
[15.]
J. Boyd, Y. Sonoda, M. Federici, F. Bogomolniy, E. Rhei, D. Maresco, et al.
Clinicopathologic features of BRCA-linked and sporadic ovarian cancer.
Jama, 283 (2000), pp. 2260-2265
[16.]
S. Thorlacius, J. Struewing, P. Hartge, G. Olafsdottir, H. Sigvaldason, L. Tyggvadottir, et al.
Population-based study of risk of breast cancer in carriers of BRCA2 mutation.
Lancet, 352 (1998), pp. 1337-1339
Copyright © 2001. Sociedad Española de Ginecología y Obstetricia